{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:19:57Z","timestamp":1793841597972,"version":"4.6.1"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:00:00Z","timestamp":1614038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Levothyroxine (L-T4) absorption can be impaired by various causes: a) L-T4 ingestion during breakfast, or with food; b) conditions of reduced gastric acidity; c) intestinal procedures and diseases such as bariatric surgery, lactose intolerance (LI), celiac disease (CD), inflammatory bowel disease; d) drugs that alter L-T4 absorption, increasing the gastric pH, or preventing the dissolution of tablets. The development of new oral formulations, i.e. the liquid preparation and the soft gel capsule, represents the most recent advance regarding L-T4 therapy. Treating hypothyroidism with L-T4 tablets can lead to an improper control of thyroid-stimulating hormone (TSH) in ~10%\u201315% of patients. The improperly elevated TSH is usually managed by increasing the L-T4 daily dose, and revaluating TSH upon 2-6 months. The increase of the L-T4 dosage may cause iatrogenic hyperthyroidism, especially when the underlying disorders are cured. Liquid L-T4 can be administered in patients unable to swallow capsules or tablets, and this is one of its major benefits. Liquid L-T4 can: 1- overcome food and beverages interference; 2- bypass the malabsorption associated with an increased gastric pH; 3- circumvent the issue of malabsorption in patients who underwent bariatric surgery; 4-maintain TSH values under control better than L-T4 tablets in hypothyroid patients with typical or atypical CD, or in patients with LI. Few clinical studies evaluated soft gel L-T4 with encouraging findings in patients with gastric- or coffee-related malabsorption, or hypothyroid patients without malabsorption. Additional research is necessary to investigate liquid L-T4, or soft gel capsule, in other conditions of altered L-T4 absorption.<\/jats:p>","DOI":"10.3389\/fendo.2021.626371","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T06:29:36Z","timestamp":1614061776000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["L-T4 Therapy in Enteric Malabsorptive Disorders"],"prefix":"10.3389","volume":"12","author":[{"given":"Poupak","family":"Fallahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Martina","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusy","family":"Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ragusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina Rosaria","family":"Paparo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2016.1227782","article-title":"Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update","volume":"14","author":"Fallahi","year":"2017","journal-title":"Expert Opin Drug Delivery"},{"key":"B2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1530\/EDM-19-0026","article-title":"Switch from tablet levothyroxine to oral solution resolved reduced absorption by intestinal parasitosis","volume":"2019","author":"Tortora","year":"2019","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1983.03340150087037","article-title":"The isolation in crystalline form of the compound containing iodin, which occurs in the thyroid. Its chemical nature and physiologic activity","volume":"250","author":"Kendall","year":"1983","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/809341","article-title":"Hypothyroidism and thyroid substitution: historical aspects","volume":"2011","author":"Lindholm","year":"2011","journal-title":"J Thyroid Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders","volume":"14","author":"Antonelli","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2019.101367","article-title":"Hashimotos\u2019 thyroiditis: Epidemiology, pathogenesis, clinic and therapy","volume":"33","author":"Ragusa","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00050","article-title":"Environmental Issues in Thyroid Diseases","volume":"8","author":"Ferrari","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3390\/nu12051337","article-title":"Nutraceuticals in Thyroidology: A Review of in Vitro, and in Vivo Animal Studies","volume":"12","author":"Benvenga","year":"2020","journal-title":"Nutrients"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2014.913021","article-title":"Thyroid dysfunctions induced by tyrosine kinase inhibitors","volume":"13","author":"Fallahi","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.0110","article-title":"Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"19","author":"Cooper","year":"2009","journal-title":"Thyroid"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2735","article-title":"Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease","volume":"97","author":"Fiore","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-010-9515-8","article-title":"Tablet splitting of a narrow therapeutic index drug: a case with levothyroxine sodium","volume":"11","author":"Shah","year":"2010","journal-title":"AAPS Pharm Sci Tech"},{"key":"B13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12020-019-02049-x","article-title":"Novel thyroxine formulations: a further step toward precision medicine","volume":"66","author":"Virili","year":"2019","journal-title":"Endocrine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12020-016-1199-8","article-title":"The emergence of levothyroxine as a treatment for hypothyroidism","volume":"55","author":"Hennessey","year":"2017","journal-title":"Endocrine"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.007","article-title":"Hashimoto thyroiditis: clinical and diagnostic criteria","volume":"13","author":"Caturegli","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/0004563216642255","article-title":"Thyroxine replacement: a clinical endocrinologist\u2019s viewpoint","volume":"53","author":"Eligar","year":"2016","journal-title":"Ann Clin Biochem"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00168","article-title":"Gastrointestinal Malabsorption of Thyroxine","volume":"40","author":"Virili","year":"2019","journal-title":"Endocr Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s40261-016-0462-3","article-title":"The economic impact of levothyroxine dose adjustments: the CONTROL HE Study","volume":"37","author":"Ernst","year":"2017","journal-title":"Clin Drug Investig"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2012.0435","article-title":"Serum thyrotropin levels following levothyroxine administration at breakfast","volume":"23","author":"Perez","year":"2013","journal-title":"Thyroid"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0860","article-title":"Timing of levothyroxine administration affects serum thyrotropin concentration","volume":"94","author":"Bach-Huynh","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2017.0428","article-title":"Concurrent Milk Ingestion Decreases Absorption of Levothyroxine","volume":"28","author":"Chon","year":"2018","journal-title":"Thyroid"},{"key":"B22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1089\/thy.2007.0222","article-title":"Altered intestinal absorption of L-thyroxine caused by coffee","volume":"18","author":"Benvenga","year":"2008","journal-title":"Thyroid"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043903","article-title":"Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis","volume":"354","author":"Centanni","year":"2006","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2008.10.008","article-title":"A comparative pH-dissolution profile study of selected commercial levothyroxine products using inductively coupled plasma mass spectrometry","volume":"72","author":"Pabla","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1995.5.249","article-title":"Delayed intestinal absorption of levothyroxine","volume":"5","author":"Benvenga","year":"1995","journal-title":"Thyroid"},{"key":"B26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1467-789X.2009.00614.x","article-title":"A systematic review of drug absorption following bariatric surgery and its theoretical implications","volume":"11","author":"Padwal","year":"2010","journal-title":"Obes Rev"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-017-0706-y","article-title":"Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report","volume":"40","author":"Centanni","year":"2017","journal-title":"J Endocrinol Investig"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2014.918101","article-title":"The administration of L-thyroxine as soft gel capsule or liquid solution","volume":"11","author":"Vita","year":"2014","journal-title":"Expert Opin Drug Delivery"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1329951","article-title":"Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs","volume":"62","author":"Yue","year":"2012","journal-title":"other Avail Dosage Forms Arzneimittelforschung"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1159\/000356047","article-title":"Congenital hypothyroidism treatment in infants: a comparative study between liquid and tablet formulations of levothyroxine","volume":"81","author":"Peroni","year":"2014","journal-title":"Horm Res Paediatr"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-014-0082-9","article-title":"Comparison between liquid and tablet levothyroxine formulations in patients treated through enteral feeding tube","volume":"37","author":"Pirola","year":"2014","journal-title":"J Endocrinol Investig"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00010","article-title":"Levothyroxine therapy: changes of TSH levels by switching patients from tablet to liquid formulation. A systematic review and meta-analysis","volume":"9","author":"Virili","year":"2018","journal-title":"Front Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12020-018-1574-8","article-title":"Liquid L-thyroxine versus tablet L-thyroxine in patients on L-thyroxine replacement or suppressive therapy: a meta-analysis","volume":"61","author":"Laurent","year":"2018","journal-title":"Endocrine"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurger.2014.09.006","article-title":"Thyroid hormonal profile in elderly patients treated with two different levothyroxine formulations: a single institute survey","volume":"5","author":"Cappelli","year":"2014","journal-title":"Eur Geriatr Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/09513590.2015.1113518","article-title":"Levothyroxine liquid solution versus tablet form for replacement treatment in pregnant women","volume":"20","author":"Cappelli","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s12020-015-0836-y","article-title":"Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study","volume":"52","author":"Fallahi","year":"2016","journal-title":"Endocrine"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4158\/EP161545.OR","article-title":"In patients with subclinical hypothyroidism while in therapy with tablet L-T4, the liquid L-T4 formulation is more effective in restoring euthyroidism","volume":"23","author":"Fallahi","year":"2017","journal-title":"Endocr Pract"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/lio2.186","article-title":"Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): a prospective study","volume":"3","author":"Fallahi","year":"2018","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11695-016-2247-4","article-title":"TSH Normalization in Bariatric Surgery Patients After the Switch from L-Thyroxine in Tablet to an Oral Liquid Formulation","volume":"27","author":"Fallahi","year":"2017","journal-title":"Obes Surg"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-012-9772-2","article-title":"A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations","volume":"43","author":"Vita","year":"2013","journal-title":"Endocrine"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1311-8","article-title":"Is levothyroxine requirement the same for tablet and soft gel formulations","volume":"59","author":"Di Donna","year":"2018","journal-title":"Endocrine"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00321","article-title":"l-thyroxine in an oral liquid or softgel formulation ensures more normal serum levels of free T4 in patients with central hypothyroidism","volume":"8","author":"Benvenga","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00118","article-title":"Thyroxine treatment with softgel capsule formulation: usefulness in hypothyroid patients without malabsorption","volume":"9","author":"Trimboli","year":"2018","journal-title":"Front Endocrinol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0693","article-title":"Oral liquid levothyroxine treatment at breakfast: a mistake","volume":"170","author":"Cappelli","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-015-0788-2","article-title":"Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation","volume":"52","author":"Morelli","year":"2016","journal-title":"Endocrine"},{"key":"B46","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/thy.2015.0422","article-title":"A Double-Blind Placebo-Controlled Trial of Liquid Thyroxine Ingested at Breakfast: Results of the TICO Study","volume":"26","author":"Cappelli","year":"2016","journal-title":"Thyroid"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1851","article-title":"Atypical celiac disease as cause of increased need for thyroxine: a systematic study","volume":"97","author":"Virili","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1217","article-title":"Systematic appraisal of lactose intolerance as cause of increased need for oral thyroxine","volume":"99","author":"Cellini","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B49","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.clinthera.2017.01.005","article-title":"Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review","volume":"39","author":"Skelin","year":"2017","journal-title":"Clin Ther"},{"key":"B50","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s12020-016-1167-3","article-title":"Tablet and oral liquid L-thyroxine formulation in the treatment of na\u00efve hypothyroid patients with Helicobacter pylori infection","volume":"57","author":"Ribichini","year":"2017","journal-title":"Endocrine"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.03993.x","article-title":"Systematic review: impaired drug absorption related to the co-administration of antisecretory therapy","volume":"29","author":"Lahner","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i30.10331","article-title":"Helicobacter pylori infection and drugs malabsorption","volume":"20","author":"Lahner","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00092","article-title":"Hashimoto\u2019s Thyroiditis and Autoimmune Gastritis","volume":"8","author":"Cellini","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1544","article-title":"L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies","volume":"93","author":"Checchi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12876-016-0439-y","article-title":"Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series","volume":"16","author":"Fallahi","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2020.02.020","article-title":"The impact of proton pump inhibitors on levothyroxine absorption: The good, the bad and the ugly","volume":"76","author":"Guzman-Prado","year":"2020","journal-title":"Eur J Intern Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2684","article-title":"Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors","volume":"99","author":"Vita","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-013-1015-y","article-title":"Oral liquid L-thyroxine (L-t4) may be better absorbed compared to L-T4 tablets following bariatric surgery","volume":"23","author":"Pirola","year":"2013","journal-title":"Obes Surg"},{"key":"B59","article-title":"The influence of lactose intolerance and other gastro-intestinal tract disorders on L-thyroxine absorption","volume":"63","author":"Rucha\u0142a","year":"2012","journal-title":"Endokrynol Pol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-013-0065-1","article-title":"Decrease in TSH levels after lactose restriction in Hashimoto\u2019s thyroiditis patients with lactose intolerance","volume":"46","author":"Asik","year":"2014","journal-title":"Endocrine"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-1090-7","article-title":"Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine","volume":"57","author":"Fallahi","year":"2017","journal-title":"Endocrine"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0947","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: Pitfalls on the replacement therapy for primary and central hypothyroidism in adults","volume":"178","author":"de Carvalho","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2015.09.011","article-title":"Celiac disease detection in hypothyroid patients requiring elevated thyroid supplementation: A prospective cohort study","volume":"26","author":"Zubarik","year":"2015","journal-title":"Eur J Intern Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1051\/parasite\/2008153261","article-title":"Pathophysiology of enteric infections with Giardia duodenalis","volume":"15","author":"Buret","year":"2008","journal-title":"Parasite"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-27302011000100012","article-title":"Increased levothyroxine requirement in a woman with previously well-controlled hypothyroidism and intestinal giardiasis","volume":"55","author":"Radaeli Rde","year":"2011","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e318217b69f","article-title":"Pharmacokinetic equivalence of a levothyroxine sodium soft capsule manufactured using the new food and drug administration potency guidelines in healthy volunteers under fasting conditions","volume":"33","author":"Colucci","year":"2011","journal-title":"Ther Drug Monit"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2014.918101","article-title":"Thyroxine softgel capsule in patients with gastric-related T4 malabsorption","volume":"49","author":"Santaguida","year":"2015","journal-title":"Endocrine"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.4158\/EP13316.CR","article-title":"Tablet levothyroxine (L-T4) malabsorption induced by proton pump inhibitor; a problem that was solved by switching to L-T4 in soft gel capsule","volume":"20","author":"Vita","year":"2014","journal-title":"Endocr Pract"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-016-0150-z","article-title":"Retrospective Study of Patients Switched from Tablet Formulations to a Gel Cap Formulation of Levothyroxine: Results of the CONTROL Switch Study","volume":"17","author":"Ernst","year":"2017","journal-title":"Drugs R D"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.626371\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T06:29:40Z","timestamp":1614061780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.626371\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,23]]},"references-count":69,"alternative-id":["10.3389\/fendo.2021.626371"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.626371","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,23]]},"article-number":"626371"}}